Current Report Filing (8-k)
December 01 2016 - 10:38AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
December 1, 2016
Date of Report (Date of
Earliest Event Reported)
IntelGenx Technologies Corp.
(Exact Name of Registrant as Specified in its
Charter)
Delaware
|
000-31187
|
870638336
|
(State or other jurisdiction of
|
(Commission File
|
(IRS Employer Identification
|
incorporation)
|
Number)
|
No.)
|
6420 Abrams, Ville St- Laurent, Quebec, Canada
|
H4S 1Y2
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code:
(514)
331-7440
Check the appropriate box below if the Form 8K fining is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule 425
under the Securities Act (17CFR230.425)
[ ] Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a
-12)
[ ] Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ]
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e -4(c))
Item 8.01 Other Events - News Release
IntelGenx Strengthens Partnership with Chemo Group by
Signing a Co-Development Term Sheet for an Additional Product
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
INTELGENX TECHNOLOGIES
CORP.
Dated: December 1, 2016
|
By: /s/
Horst G. Zerbe
|
|
-------------------
|
|
Horst G. Zerbe
|
|
President and Chief Executive Officer
|
IntelGenx Technologies (QB) (USOTC:IGXT)
Historical Stock Chart
From Mar 2024 to Apr 2024
IntelGenx Technologies (QB) (USOTC:IGXT)
Historical Stock Chart
From Apr 2023 to Apr 2024